Vaccination against meningococcal disease

Vaccination against meningococcal serogroups C and W is effective, has few adverse effects and could lead to herd immunity. The Health Council recommends adding this vaccination to the national immunisation programme for 14-year-olds and continuing vaccination at 14 months of age.

Vaccination against meningococcal serogroup B is not included in the national immunisation programme. A different type of vaccine is required for protection against serogroup B. This vaccine is available, but its effectiveness remains unclear. It is known that it can cause high fever, especially in young infants. Taken together, the Health Council does not recommend adding this vaccination to the national immunisation programme.